Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. [electronic resource]
Producer: 19780417Description: 897-903 p. digitalISSN:- 0002-9343
- Antineoplastic Agents -- therapeutic use
- Carmustine -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Drug Therapy, Combination
- Female
- Humans
- Immunoglobulin A
- Immunoglobulin G
- Immunoglobulin M
- Male
- Melphalan -- therapeutic use
- Middle Aged
- Multiple Myeloma -- drug therapy
- Prednisone -- therapeutic use
- Remission, Spontaneous
- Time Factors
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.